The effect of Valsalva maneuver and Lidocaine injection on reducing the pain of Etomidate injectio

Phase 2

• Conditions: G89.18; ocal injection site pain.; Other acute postprocedural pain

• Registration Number: IRCT20160307026950N26
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Candidates for general anesthesia
Physical condition in ASA class I and II
Age 18 to 65 years
Able to perform Valsalva maneuver

Exclusion Criteria

History of mental, cardiac and respiratory diseases
Chronic pain disorders
Long history of analgesic use
History of allergies to Etomidate and Lidocaine
History of drug abuse

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ocal etomidate injection site pain measured by visual analog scale. Timepoint: Right after etomidate injection. Method of measurement: visual analog scale / Objective physician-assessed pain score; with: 0= no pain;1= mild pain, pain that only is reported by the patient, and no signs of pain are observed by the physician;2= Moderate pain, one pain sign is observed in addition to patient's report3= Severe pain with loud noise or moaning.